Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-03

Clinical Trial Update: Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD

View source ↗

Summary

A study update examining recurrence and predictive OCT biomarkers in quiescent neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Erik Eye Hospital | Conditions: Retinal Diseases, Macular Degeneration | Status: ACTIVE_NOT_RECRUITING